David Bernstein

David Bernstein is the Senior Director of Science and Strategy for Stand Up To Cancer and is based in New York. David oversees the development of new scientific projects and grants at SU2C, as well as the translation of grantees’ achievements for lay audiences. SU2C grants generally support milestone-driven, multi-investigator, multi-institutional collaborative research projects that span many disciplines within and beyond the biological sciences and medicine.  

Following a Ph.D. in biochemistry from the University of Wisconsin-Madison, David was awarded a AAAS Congressional Fellowship and served on the Senate Health, Education, Labor and Pensions Committee staff. One of his main focuses during this time were public health issues related to community-level preparation and response to infectious disease and bioterrorism. After the Fellowship, David was the Senior Science Policy Analyst at the American Association for Cancer Research (AACR), the first full-time member of their government relations department, and contributed to SU2C scientific reviews in addition to managing Congressional and Executive branch policy issues impacting cancer research. David then became Associate Director of Research Policy at the American Society of Clinical Oncology (ASCO). There he managed FDA collaborations, developed the Society’s input on regulatory policy, and coauthored papers on clinical trial design.